NCT03834168

Brief Summary

The purpose of the study to assess the diurnal rhythm in natriuretic peptide levels and its temporal relationship with nocturnal blood pressure in obese and African-American individuals as compared with lean and white individuals.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
42

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Apr 2019

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 6, 2019

Completed
1 day until next milestone

First Posted

Study publicly available on registry

February 7, 2019

Completed
2 months until next milestone

Study Start

First participant enrolled

April 1, 2019

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 29, 2020

Completed
1.1 years until next milestone

Study Completion

Last participant's last visit for all outcomes

March 31, 2021

Completed
5 months until next milestone

Results Posted

Study results publicly available

August 31, 2021

Completed
Last Updated

February 5, 2024

Status Verified

January 1, 2024

Enrollment Period

11 months

First QC Date

February 6, 2019

Results QC Date

May 28, 2021

Last Update Submit

January 10, 2024

Conditions

Keywords

Diurnal RhythmRace

Outcome Measures

Primary Outcomes (1)

  • Plasma MRproANP

    Assess the diurnal rhythm in circulating MRproANP levels among obese individuals and compared it with lean individuals

    About 24 hours on the in-patient study visit day after consuming study meals for 5 days

Secondary Outcomes (1)

  • Acrophase Difference in Hours Between the MR-proANP and Systolic BP Rhythm

    About 24 hours on the in-patient study visit day after consuming study meals for 5 days

Other Outcomes (1)

  • Plasma MRproANP

    About 24 hours on the in-patient study visit day after consuming study meals for 5 days

Study Arms (1)

Study Individuals

OTHER

Healthy self-identified African-American and white male participants will be screened. Study consent will be obtained, medical history and physical examination administered, and study eligibility determined based on the inclusion and exclusion criteria. Eligible subjects will meet a bio-nutritionist who will explain the 5 days of standardized diet at the screening visit and will review instructions for complying with the diet. If the subject agrees to adhere to the study diet, they will then be enrolled in the study (stratified by race).

Other: standardized Study Diet

Interventions

Standardized diet consisted with eucaloric meals with 4.5 gm of sodium per day for 5 days.

Study Individuals

Eligibility Criteria

Age18 Years - 40 Years
Sexmale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Age 18 to 40 years
  • Blood pressure less than 140/90
  • Body Mass Index between 18.5 to 25 kg/m2 (lean) or 30 to 45 kg/m2 (obese)
  • Self identified African-American or white individuals
  • Willingness to comply with the study diet
  • Provide informed consent

You may not qualify if:

  • History of hypertension
  • History of cardiovascular, renal, or liver disease
  • Diabetes or use of glucose-lowering medications
  • Use of vasoactive or diuretic medications
  • Atrial fibrillation
  • Anemia (Hematocrit \<41%)
  • Abnormal serum sodium or potassium
  • Abnormal liver function tests (\>3x upper limit of normal)
  • Current smokers
  • Regular users of non-steroid anti-inflammatory medications

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Alabama at Birmingham

Birmingham, Alabama, 35294, United States

Location

Related Publications (5)

  • Goetze JP, Jorgensen HL, Sennels HP, Fahrenkrug J. Diurnal plasma concentrations of natriuretic propeptides in healthy young males. Clin Chem. 2012 Apr;58(4):789-92. doi: 10.1373/clinchem.2011.178921. Epub 2012 Jan 26. No abstract available.

    PMID: 22282468BACKGROUND
  • Arora P, Reingold J, Baggish A, Guanaga DP, Wu C, Ghorbani A, Song Y, Chen-Tournaux A, Khan AM, Tainsh LT, Buys ES, Williams JS, Heublein DM, Burnett JC, Semigran MJ, Bloch KD, Scherrer-Crosbie M, Newton-Cheh C, Kaplan LM, Wang TJ. Weight loss, saline loading, and the natriuretic peptide system. J Am Heart Assoc. 2015 Jan 16;4(1):e001265. doi: 10.1161/JAHA.114.001265.

    PMID: 25595796BACKGROUND
  • Bajaj NS, Gutierrez OM, Arora G, Judd SE, Patel N, Bennett A, Prabhu SD, Howard G, Howard VJ, Cushman M, Arora P. Racial Differences in Plasma Levels of N-Terminal Pro-B-Type Natriuretic Peptide and Outcomes: The Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study. JAMA Cardiol. 2018 Jan 1;3(1):11-17. doi: 10.1001/jamacardio.2017.4207.

    PMID: 29167879BACKGROUND
  • Arora P, Wu C, Hamid T, Arora G, Agha O, Allen K, Tainsh RET, Hu D, Ryan RA, Domian IJ, Buys ES, Bloch DB, Prabhu SD, Bloch KD, Newton-Cheh C, Wang TJ. Acute Metabolic Influences on the Natriuretic Peptide System in Humans. J Am Coll Cardiol. 2016 Feb 23;67(7):804-812. doi: 10.1016/j.jacc.2015.11.049.

    PMID: 26892417BACKGROUND
  • Parcha V, Patel N, Gutierrez OM, Li P, Gamble KL, Musunuru K, Margulies KB, Cappola TP, Wang TJ, Arora G, Arora P. Chronobiology of Natriuretic Peptides and Blood Pressure in Lean and Obese Individuals. J Am Coll Cardiol. 2021 May 11;77(18):2291-2303. doi: 10.1016/j.jacc.2021.03.291.

MeSH Terms

Conditions

Obesity

Condition Hierarchy (Ancestors)

OverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Results Point of Contact

Title
Dr. Pankaj Arora
Organization
UNIVERSITY OF ALABAMA AT BIRMINGHAM

Study Officials

  • Pankaj Arora, MD

    University of Alabama at Birmingham

    PRINCIPAL INVESTIGATOR
  • Orlando M Gutierrez, MMSc

    University of Alabama at Birmingham

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

February 6, 2019

First Posted

February 7, 2019

Study Start

April 1, 2019

Primary Completion

February 29, 2020

Study Completion

March 31, 2021

Last Updated

February 5, 2024

Results First Posted

August 31, 2021

Record last verified: 2024-01

Data Sharing

IPD Sharing
Will not share

Locations